Technology Commercialization Transactions and Contracts

We are familiar with legal activities, transactions and documents encountered by technology companies as they move innovations from invention to the marketplace.  We have great experience assisting clients with dealing with the legal aspects of technology commercialization transactions. We advise clients in negotiating and drafting technology commercialization contracts.  These legal agreements include:

• Founder’s Agreements
• Confidentiality Agreements
• IP Assignments
• Financing Agreements
• Shareholders Agreements
• License and Services Agreements
• Asset and Share Purchase/Sale Agreements

Significant Transactions

• We advised a large, not-for-profit in the healthcare sector in drafting and negotiating a series of agreements related to outsourced IT data security services for technology commercialization, including, contracts for security incident and event monitoring, security incident response and CISO-as-a-service.
• Advised Ventures West on Investments in Jaldi Semiconductors and Audesi (i.e. on financing transactions and IP due diligence).  Total exits for these were >100 million
• Advised on investment in Plazmic Inc., and then became “virtual general counsel” for Plazmic.  Plazmic was bought by RIM for $26 million which was the Canadian Venture Capital Association deal of the year in 2002, providing a 65% IRR to investors, in aggregate (of course the early stage investors did much better).
• Advised Forbius Biologics (then known as Avid Biologics and then Formation Biologics) on multiple rounds of investment, due diligence and renegotiating license agreement with National Research Council of Canada. Forbius was acquired by Bristol Myers Squibb in 2020.
• Advised Q1 Labs of Fredericton New Brunswick on IP Strategy and Due Diligence through multiple rounds of financing. Also lead legal action against former CEO of the Company who was accused of misappropriating confidential information and breaching restrictive covenants and fiduciary duties. Q1 Labs was acquired by IBM in 2011 for an amount reported to be in excess of US $600million
• Advised Au-Zone Technologies on strategic license agreement and investment from NXP BV

We also have extensive experience in transactions and agreements specific to specific industries, such as:

• IT Development and Outsourcing Agreements
• Privacy and Data Security Agreements
• Clinical Trial Agreements
• Research Agreements

In relation to all of these, we have carried out due diligence and negotiations hundreds of times.